Article Text

Download PDFPDF
Severe myopericarditis following the third dose of an mRNA COVID-19 vaccine: utility of a multimodal treatment approach

Abstract

We report a rare case of severe myopericarditis in a healthy man in his 20s after the third dose of an mRNA COVID-19 vaccine. His symptoms and troponinemia resolved with a beta-blocker in addition to standard anti-inflammatory therapy, highlighting the utility of multimodal therapy.

  • Cardiovascular medicine
  • Pericardial disease
  • COVID-19
  • Immunological products and vaccines

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.